PvP Biologics, Inc.

Who: Takeda/Innate Pharma What: Takeda is licensing antibodies discovered by Innate for use in antibody-drug conjugate therapeutics for celiac disease. Why: Celiac disease is a major focus of Tak

Takeda Pharmaceutical Co. Ltd. has acquired the private San Diego-based venture PvP Biologics Inc. , following promising early clinical results with the university spin-out’s candidate for celiac di

Venture capital fundraising by biopharmaceutical companies totaled $5.7bn during the first quarter of 2020 – the second-highest amount ever raised by the industry in a single quarter – as private drug

Biopharma R&D today remains a high-interest promissory note on the future of medicine. Redeeming that note periodically with therapies that advance the standard of care allows the drugmaker to survive